| 英文别名 |
Omaveloxolone;RTA408;RTA-408;RTA408; Omaveloxolone;NRF1-ACTIVATOR-1;Omaveloxolone [INN];SKYCLARYS;AKOS037648676;Q21098900;N-((4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,12a,14,14a,14b-octadecahydropicen-4a-yl)-2,2-difluoropropanamide;N-((4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-Cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,6a,6b,7,8,8a,9,10,12a,14,14a,14b-hexadecahydropicen-4a(2H)-yl)-2,2-difluoropropanamide;OMAVELOXOLONE [USAN];omaveloxolona;N-[(4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14b-decahydropicen-4a-yl]-2,2-difluoropropanamide;Omaveloxolone (USAN/INN);BCP28609;Skyclarys (TN);omaveloxolonum;N-(2-cyano-3,12-dioxo-28-noroleana-1,9(11)-dien-17-yl)-2,2-difluoropropanamide;N-(11-cyano-2,2,6a,6b,9,9,12a-heptmethyl-10,14-dioxo-1,3,4,5,6a,6b,7,8,8a,9,10,12a,14,14a,14b-hexadecahydro-2H-picen-4a-yl)-2-2-difluoropropionamide;GTPL7573;SCHEMBL15349371;CHEMBL4303525;DTXSID101138251;BRD-K56211775-001-01-2;UNII-G69Z98951Q;G69Z98951Q;EX-A541;HY-12212;RTA 408;BS-15146;RTA-408(Omaveloxolone)?;D10964;Propanamide, N-(2-cyano-3,12-dioxo-28-noroleana-1,9(11)-dien-17-yl)-2,2-difluoro-;RJCWBNBKOKFWNY-IDPLTSGASA-N;AC-37100;N-(2-Cyano-3,12-dioxo-28-noroleana-1,9(11)-dien-17-yl)-2,2-difluoropropanamide; Omaveloxolone;N-[(4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,6a,6b,7,8,8a,9,10,12a,14,14a,14b-hexadecahydropicen-4a(2H)-yl]-2,2-difluoropropanamide;CHEBI:229661;OMAVELOXOLONE [WHO-DD];DB12513;MFCD28167769;1474034-05-3;RTA408; RTA408; RTA-408;Nrf1-activator-1;NS00073426;Nrf1-activator-1 |
微信公众号
客服
